Filter
2097
Text search:
controlled
drugs
Featured
Recommendations
245
New Publications
451
Language
Document type
No document type
1200
Guidelines
388
Studies & Reports
285
Manuals
118
Strategic & Response Plan
45
Fact sheets
24
Training Material
23
Situation Updates
6
Brochures
4
Resource Platforms
2
Infographics
2
Countries / Regions
India
136
Global
64
Kenya
55
South Africa
55
Uganda
41
Western and Central Europe
41
Ethiopia
36
Nigeria
34
Tanzania
33
Africa
30
Latin America and the Carribbean
29
Sierra Leone
28
Nepal
28
Malawi
28
Ukraine
27
Zambia
26
Eastern Europe
25
Philippines
22
Rwanda
22
Ghana
20
Liberia
19
Bangladesh
18
Myanmar / Burma
18
Zimbabwe
17
Russia
17
Syria
15
Indonesia
15
Asia
13
Lesotho
12
South–East Asia Region
12
South Sudan
11
Namibia
11
Eswatini/ Swaziland
11
Brazil
11
Mozambique
10
Colombia
9
Burkina Faso
8
Botswana
8
Congo, Democratic Republic of
7
Germany
7
East and Southern Africa
7
Venezuela
7
Guinea
6
Cameroon
6
Afghanistan
6
Yemen
6
Haiti
5
Lebanon
5
Thailand
5
Sudan
5
Tajikistan
5
Senegal
4
Jordan
4
West and Central Africa
4
Eastern Europe and Central Asia
4
North America
4
Mali
3
USA
3
Pakistan
3
Iraq
3
Cambodia
3
Central African Republic
3
Argentina
3
Angola
3
Madagascar
3
Middle East and North Africa
3
Paraguay
3
Iran
3
Georgia
3
Guinea-Bissau
2
Morocco
2
Saudi Arabia
2
Somalia
2
Egypt
2
China
2
North Macedonia
2
Hungary
2
Ecuador
2
Libya
2
Mexico
2
Sri Lanka
2
Palestine
2
Albania
2
Canada
2
Lithuania
2
Kyrgyzstan
2
Vietnam
2
Jamaica
2
Côte d’Ivoire / Ivory Coast
1
Turkey
1
Singapore
1
Papua New Guinea
1
Benin
1
Peru
1
Serbia
1
Burundi
1
Bolivia
1
Greece
1
Chile
1
Western Pacific Region
1
Bhutan
1
Poland
1
Djibouti
1
Armenia
1
Laos
1
Qatar
1
Moldova
1
Australia
1
Kazakhstan
1
Gabon
1
Denmark
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
689
Clinical Guidelines
287
Public Health
122
Women & Child Health
102
Key Resources
59
Pharmacy & Technologies
27
Capacity Building
22
Toolboxes
Mental Health
289
HIV
221
TB
173
COVID-19
97
NTDs
84
Pharmacy
81
NCDs
80
AMR
67
Caregiver
55
Ebola & Marburg
38
Malaria
37
Conflict
33
Refugee
25
Disability
22
Rapid Response
17
Planetary Health
17
Cholera
14
Global Health Education
14
Natural Hazards
12
Polio
7
Health Financing Toolbox
7
Zika
6
Specific Hazards
6
2.0 Rapid Response
3
Social Ethics
2
Drug Advisory Board
This guideline is intended to provide requirements to applicants wishing to submit
applications for registration of medicines in Botswana.
EACS produces Guidelines for the management of people living with HIV in Europe. The English version is regularly updated by the guidelines panels with major revision every other year and minor revisions in the years in between. Guidelines are published in the autumn and translated into additional l
...
Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach model of service delivery?
Mental Health First Aid Guidelines
Accessed: 14.03.2019
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt
...
National Medicines Policy 2015
recommended
SCOPING QUESTION: In the management of prescription opioid dependence, does supervised dosing with a long-acting opioid medication result in less opioid use and related harms than non-prescription, detoxification or usual care?
AIDS Research and Therapy 2015, 12:12 (24 April 2015)
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin for the prevention and treatment of COVID-19 by the public in African Union Member States.
Currently
...
ATLAS on substance use (2010)— Resources for the prevention and treatment of substance use disorder
Accessed: 14.03.2019
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.